Fluorouracil
Showing 51 - 75 of 2,922
Bladder Cancer Trial in Canada, United States (drug, radiation, procedure)
Completed
- Bladder Cancer
- induction cisplatin
- +13 more
-
Atlanta, Georgia
- +10 more
May 23, 2022
Stage III Hepatocellular Carcinoma AJCC v8, Stage IIIA Hepatocellular Carcinoma AJCC v8, Stage IIIB Hepatocellular Carcinoma
Recruiting
- Stage III Hepatocellular Carcinoma AJCC v8
- +6 more
- Fluorouracil
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Nov 18, 2021
Advanced/Metastatic Colorectal Cancer Trial in Guangzhou (Dalpiciclib, Oxaliplatin injection, Calcium folinate)
Not yet recruiting
- Advanced/Metastatic Colorectal Cancer
- Dalpiciclib
- +3 more
-
Guangzhou, Guangdong, ChinaSixth Affiliated Hospital, Sun Yat-sen University
Jul 28, 2022
Biliary Tract Cancer Trial in United States (Nivolumab, Nanoliposomal-Irinotecan, 5-Fluorouracil)
Active, not recruiting
- Biliary Tract Cancer
- Nivolumab
- +3 more
-
Ann Arbor, Michigan
- +4 more
Oct 6, 2022
Oral Squamous Cell Carcinoma, Neoadjvant Therapy, Anti-PD-1 Trial in Shanghai (Toripalimab (anti-programmed death-1 inhibitor),
Recruiting
- Oral Squamous Cell Carcinoma
- +3 more
- Toripalimab (anti-programmed death-1 inhibitor)
- +4 more
-
Shanghai, Shanghai, ChinaNinth People's Hospital, Shanghai Jiao Tong University School of
Oct 8, 2022
Pancreatic Cancer Trial in Nanjing (Cadonilimab+mFOLFIRINOX)
Not yet recruiting
- Pancreatic Cancer
-
Nanjing, Jiangsu, ChinaThe First Affiliated Hospital with Nanjing Medical University
Nov 23, 2023
Colorectal Cancer Trial in Philadelphia (Regorafenib, 5-FU, Leucovorin)
Terminated
- Colorectal Cancer
- Regorafenib
- +2 more
-
Philadelphia, PennsylvaniaFox Chase Cancer Center
Jan 10, 2022
Gastric Cancer, Stomach Cancer, GastroEsophageal Cancer Trial in Kyiv (Docetaxel, Oxaliplatin, Leucovorin)
Recruiting
- Gastric Cancer
- +10 more
- Docetaxel
- +3 more
-
Kyiv, UkraineNational Cancer Institute
Aug 31, 2023
Carcinoma, Squamous Cell of Head and Neck Trial in Darmstadt (Cetuximab, Cisplatin/Carboplatin, 5-fluorouracil)
Completed
- Carcinoma, Squamous Cell of Head and Neck
- Cetuximab
- +2 more
-
Darmstadt, GermanyResearch site
Apr 19, 2022
Clinical Stage II Esophageal Adenocarcinoma AJCC v8, Clinical Stage III Esophageal Adenocarcinoma AJCC v8, Clinical Stage III
Recruiting
- Clinical Stage II Esophageal Adenocarcinoma AJCC v8
- +10 more
- Biopsy
- +8 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Jan 20, 2023
Unresectable Locally Advanced, Recurrent or Metastatic Esophageal Squamous Cell Carcinoma Trial in Shanghai (CS1001+
Active, not recruiting
- Unresectable Locally Advanced, Recurrent or Metastatic Esophageal Squamous Cell Carcinoma
- CS1001+ Fluorouracil+Cisplatin
- Placebo+ Fluorouracil+Cisplatin
-
Shanghai, Shanghai, ChinaShanghai East Hospital
Mar 20, 2022
Colorectal Cancer Trial in Guangzhou (mFOLFOXIRI plus Bevacizumab, mFOLFOX6 Plus Bevacizumab)
Recruiting
- Colorectal Cancer
- mFOLFOXIRI plus Bevacizumab
- mFOLFOX6 Plus Bevacizumab
-
Guangzhou, Guangdong, ChinaGastrointestinal Hospital, Sun Yat-sen University
Jun 15, 2022
Colorectal Cancer, Esophagus Cancer, Appendix Cancer Trial (FOX dose-escalation algorithm)
Not yet recruiting
- Colorectal Cancer
- +4 more
- FOX dose-escalation algorithm
- (no location specified)
Mar 24, 2023
Tumor Neck Trial in Shanghai (docetaxel, cisplatin and 5-fluorouracil)
Recruiting
- Neoplasm Neck
- docetaxel, cisplatin and 5-fluorouracil
-
Shanghai, Shanghai, ChinaNinth People's Hospital, School of Medicine, Shanghai Jiao Tong
Oct 5, 2022
Nasopharyngeal Carcinoma, Nasopharyngeal Tumors, Nasopharyngeal Diseases Trial in Guangzhou (gemcitabine and cisplatin,
Recruiting
- Nasopharyngeal Carcinoma
- +3 more
- gemcitabine and cisplatin
- +3 more
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
May 4, 2022
Advanced Biliary Tract Cancer Trial in Washington, Indianapolis, Saint Louis (Nanoliposomal Irinotecan, Leucovorin,
Recruiting
- Advanced Biliary Tract Cancer
- Nanoliposomal Irinotecan
- +2 more
-
Washington, District of Columbia
- +2 more
Oct 29, 2021
Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Ductal Adenocarcinoma Trial in Los Angeles
Not yet recruiting
- Borderline Resectable Pancreatic Adenocarcinoma
- Locally Advanced Pancreatic Ductal Adenocarcinoma
- Biospecimen Collection
- +9 more
-
Los Angeles, CaliforniaYonemoto,Lisa
Jan 13, 2023
Chemo Induced Peripheral Neuropathy Trial (Omeprazole)
Not yet recruiting
- Chemotherapy Induced Peripheral Neuropathy
- (no location specified)
Jan 10, 2023
Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Adenocarcinoma of the Gastric Cardia Trial in
Active, not recruiting
- Adenocarcinoma of the Esophagus
- +5 more
- oxaliplatin
- +6 more
-
Cleveland, OhioCleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Jul 25, 2022
GastroEsophageal Cancer Trial in Boston (Irinotecan, Oxaliplatin, Leucovorin)
Active, not recruiting
- GastroEsophageal Cancer
- Irinotecan
- +6 more
-
Boston, MassachusettsMassachusetts General Hospital
Sep 7, 2022
Cancer of Pancreas, Chemo Effect, Metastatic Pancreatic Cancer Trial in Shibin Al Kawm (Gemcitabine fluorouracil)
Completed
- Cancer of Pancreas
- +2 more
- Gemcitabine fluorouracil
-
Shibīn Al Kawm, Menoufia, EgyptMenoufia University, Faculty of medicine
Aug 5, 2022
Plantar Wart Trial in Sohag (Bleomycin and 5-fluorouracil)
Not yet recruiting
- Plantar Wart
- Bleomycin and 5-fluorouracil
-
Sohag, EgyptSohag Faculty of Medicine
Sep 26, 2021
Gastric Adenocarcinoma, Oligometastasis, Stage IV Esophageal Adenocarcinoma AJCC v7 Trial in Houston (drug, procedure,
Recruiting
- Gastric Adenocarcinoma
- +4 more
- Capecitabine
- +4 more
-
Houston, TexasM D Anderson Cancer Center
Sep 20, 2022
Cervical Esophagus Adenocarcinoma, Clinical Stage II Esophageal Adenocarcinoma AJCC v8, Clinical Stage IIA Esophageal
Recruiting
- Cervical Esophagus Adenocarcinoma
- +12 more
- Capecitabine
- +8 more
-
Houston, TexasM D Anderson Cancer Center
Dec 31, 2022